Skip to content

Change in Inventories at other companies

Pfizer logo
PfizerPFE
-$140.25M-166%
Amgen logo
AmgenAMGN
-$18M+93.8%
Incyte logo
IncyteINCY
$12.23M-57.2%
Organon logo
OrganonOGN
$9M+400%
Ligand Pharmaceuticals logo
Ligand PharmaceuticalsLGND
$4.14M+728%
LQD
Liquidia CorporationLQDA
$4.57M+312%

Other financials

Income statement

See full
Revenue$105.4M+60.1%
Gross profit$95.6M+67.7%
Operating income-$9.1M+62.9%
Net income-$11.3M+54.9%
EPS (diluted)-$0.09+55.0%

Balance sheet

See full
Cash & equivalents$35.1M-34.7%
Total debt$114.7M+3.5%
Total equity$189.6M+32.9%
Total assets$460.0M+33.7%

Cash flow

See full
Operating cash flow$2.2M+107%
CapEx--100%
Free cash flow$2.2M+107%

Valuation

See full
Market cap$3.29B+57.5%

Profitability

See full
Gross margin90.9%+2.5pp
Operating margin-12%-5.7pp
Net margin-13.9%-6.6pp
FCF margin-52.5%-21.9pp

Returns & leverage

See full
Return on equity-28.2%-13.0pp
Debt / equity0.6×-0.2×
Current ratio2.7×-0.9×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInInventories.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s change in inventories.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s change in inventories?
Arcutis Biotherapeutics, Inc. (ARQT) reported change in inventories of $14.58M in Q1 2026.
How has Arcutis Biotherapeutics, Inc.'s change in inventories changed year-over-year?
Arcutis Biotherapeutics, Inc.'s change in inventories increased by 647.3% year-over-year, from $1.95M to $14.58M.
What does change in inventories mean?
Increase or decrease in inventory levels, directly affecting operating cash flow and working capital.